Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rina Nishii

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Journal of Pharmaceutical Sciences|May 30, 2025
Evaluating the utility of endogenous OCT2 and MATE1/2-K biomarkers for DDI assessment in early clinical settingsRina Nishii, Yongjun Xue, Runlan Huo, et al.
Pharmacogenetics and Genomics|June 6, 2022
PharmGKB summary: acyclovir/ganciclovir pathwayMaud Maillard, Li Gong, Rina Nishii, et al.
Cancer Chemotherapy and Pharmacology|November 13, 2023
Relative bioavailability of fedratinib through various alternative oral administration methods in healthy adultsYizhe Chen, David Wyatt, Massimo Attanasio, et al.
The Journal of Clinical Investigation|July 15, 2025
The NUDIX hydrolase NUDT5 regulates thiopurine metabolism and cytotoxicityMaud Maillard, Rina Nishii, Hieu S Vu, et al.
Pharmacogenetics and Genomics|April 27, 2017
The effects of inherited NUDT15 polymorphisms on thiopurine active metabolites in Japanese children with acute lymphoblastic leukemiaTakaya Moriyama, Rina Nishii, Ting-Nien Lin, et al.
The Journal of Biological Chemistry|March 23, 2021
Crystal structures of NUDT15 variants enabled by a potent inhibitor reveal the structural basis for thiopurine sensitivityDaniel Rehling, Si Min Zhang, Ann-Sofie Jemth, et al.
Journal of the National Cancer Institute|October 24, 2017
Loss of DNA Damage Response in Neuroblastoma and Utility of a PARP InhibitorMasatoshi Takagi, Misa Yoshida, Yoshino Nemoto, et al.
Nature Communications|July 8, 2021
NUDT15 polymorphism influences the metabolism and therapeutic effects of acyclovir and ganciclovirRina Nishii, Takanori Mizuno, Daniel Rehling, et al.
Blood|June 30, 2017
Novel variants in <i>NUDT15</i> and thiopurine intolerance in children with acute lymphoblastic leukemia from diverse ancestryTakaya Moriyama, Yung-Li Yang, Rina Nishii, et al.
Research Square|July 28, 2023
Germline Genetic <i>NBN</i> Variation and Predisposition to B-cell Acute Lymphoblastic Leukemia in ChildrenCarolin Escherich, Wenan Chen, Yizhen Li, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Journal of Pharmaceutical Sciences|May 30, 2025
Evaluating the utility of endogenous OCT2 and MATE1/2-K biomarkers for DDI assessment in early clinical settingsRina Nishii, Yongjun Xue, Runlan Huo, et al.
Pharmacogenetics and Genomics|June 6, 2022
PharmGKB summary: acyclovir/ganciclovir pathwayMaud Maillard, Li Gong, Rina Nishii, et al.
Cancer Chemotherapy and Pharmacology|November 13, 2023
Relative bioavailability of fedratinib through various alternative oral administration methods in healthy adultsYizhe Chen, David Wyatt, Massimo Attanasio, et al.
The Journal of Clinical Investigation|July 15, 2025
The NUDIX hydrolase NUDT5 regulates thiopurine metabolism and cytotoxicityMaud Maillard, Rina Nishii, Hieu S Vu, et al.
Pharmacogenetics and Genomics|April 27, 2017
The effects of inherited NUDT15 polymorphisms on thiopurine active metabolites in Japanese children with acute lymphoblastic leukemiaTakaya Moriyama, Rina Nishii, Ting-Nien Lin, et al.
The Journal of Biological Chemistry|March 23, 2021
Crystal structures of NUDT15 variants enabled by a potent inhibitor reveal the structural basis for thiopurine sensitivityDaniel Rehling, Si Min Zhang, Ann-Sofie Jemth, et al.
Journal of the National Cancer Institute|October 24, 2017
Loss of DNA Damage Response in Neuroblastoma and Utility of a PARP InhibitorMasatoshi Takagi, Misa Yoshida, Yoshino Nemoto, et al.
Nature Communications|July 8, 2021
NUDT15 polymorphism influences the metabolism and therapeutic effects of acyclovir and ganciclovirRina Nishii, Takanori Mizuno, Daniel Rehling, et al.
Blood|June 30, 2017
Novel variants in <i>NUDT15</i> and thiopurine intolerance in children with acute lymphoblastic leukemia from diverse ancestryTakaya Moriyama, Yung-Li Yang, Rina Nishii, et al.
Research Square|July 28, 2023
Germline Genetic <i>NBN</i> Variation and Predisposition to B-cell Acute Lymphoblastic Leukemia in ChildrenCarolin Escherich, Wenan Chen, Yizhen Li, et al.
Pageof 3